273 related articles for article (PubMed ID: 10940440)
1. The role of the locus coeruleus in the development of Parkinson's disease.
Gesi M; Soldani P; Giorgi FS; Santinami A; Bonaccorsi I; Fornai F
Neurosci Biobehav Rev; 2000 Aug; 24(6):655-68. PubMed ID: 10940440
[TBL] [Abstract][Full Text] [Related]
2. In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson's disease using neuromelanin-sensitive MRI: Replication in two cohorts.
Hwang KS; Langley J; Tripathi R; Hu XP; Huddleston DE
PLoS One; 2023; 18(4):e0282684. PubMed ID: 37053195
[TBL] [Abstract][Full Text] [Related]
3. The functional anatomy of noradrenergic neurons in Parkinson's disease.
Soldani P; Fornai F
Funct Neurol; 1999; 14(2):97-109. PubMed ID: 10399622
[No Abstract] [Full Text] [Related]
4. Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease.
Mavridis M; Degryse AD; Lategan AJ; Marien MR; Colpaert FC
Neuroscience; 1991; 41(2-3):507-23. PubMed ID: 1870701
[TBL] [Abstract][Full Text] [Related]
5. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
[TBL] [Abstract][Full Text] [Related]
6. Locus coeruleus.
Benarroch EE
Cell Tissue Res; 2018 Jul; 373(1):221-232. PubMed ID: 28687925
[TBL] [Abstract][Full Text] [Related]
7. Noradrenaline in Parkinson's disease: from disease progression to current therapeutics.
Fornai F; di Poggio AB; Pellegrini A; Ruggieri S; Paparelli A
Curr Med Chem; 2007; 14(22):2330-4. PubMed ID: 17896981
[TBL] [Abstract][Full Text] [Related]
8. Noradrenergic pathways of locus coeruleus in Parkinson's and Alzheimer's pathology.
Singh S
Int J Neurosci; 2020 Mar; 130(3):251-261. PubMed ID: 31575316
[TBL] [Abstract][Full Text] [Related]
9. Locus Coeruleus atrophy doesn't relate to fatigue in Parkinson's disease.
Solopchuk O; Sebti M; Bouvy C; Benoit CE; Warlop T; Jeanjean A; Zénon A
Sci Rep; 2018 Aug; 8(1):12381. PubMed ID: 30120287
[TBL] [Abstract][Full Text] [Related]
10. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH
Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.
Srinivasan J; Schmidt WJ
Eur J Neurosci; 2003 Jun; 17(12):2586-92. PubMed ID: 12823465
[TBL] [Abstract][Full Text] [Related]
12. Locus coeruleus and norepinephrine in Parkinson's disease.
Chan-Palay V
Jpn J Psychiatry Neurol; 1991 Jun; 45(2):519-21. PubMed ID: 1722263
[No Abstract] [Full Text] [Related]
13. Nexus between mitochondrial function, iron, copper and glutathione in Parkinson's disease.
Liddell JR; White AR
Neurochem Int; 2018 Jul; 117():126-138. PubMed ID: 28577988
[TBL] [Abstract][Full Text] [Related]
14. Image analyser-assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
Hoogendijk WJ; Pool CW; Troost D; van Zwieten E; Swaab DF
Brain; 1995 Feb; 118 ( Pt 1)():131-43. PubMed ID: 7894999
[TBL] [Abstract][Full Text] [Related]
15. Possible role of neuromelanin in the pathogenesis of Parkinson's disease.
Mann DM; Yates PO
Mech Ageing Dev; 1983 Feb; 21(2):193-203. PubMed ID: 6865505
[TBL] [Abstract][Full Text] [Related]
16. Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging.
Ohtsuka C; Sasaki M; Konno K; Koide M; Kato K; Takahashi J; Takahashi S; Kudo K; Yamashita F; Terayama Y
Neurosci Lett; 2013 Apr; 541():93-8. PubMed ID: 23428505
[TBL] [Abstract][Full Text] [Related]
17. Enhanced firing of locus coeruleus neurons and SK channel dysfunction are conserved in distinct models of prodromal Parkinson's disease.
Matschke LA; Komadowski MA; Stöhr A; Lee B; Henrich MT; Griesbach M; Rinné S; Geibl FF; Chiu WH; Koprich JB; Brotchie JM; Kiper AK; Dolga AM; Oertel WH; Decher N
Sci Rep; 2022 Feb; 12(1):3180. PubMed ID: 35210472
[TBL] [Abstract][Full Text] [Related]
18. Self-amplification of nigral degeneration in Parkinson's disease: a hypothesis.
Ionov ID
Int J Neurosci; 2008 Dec; 118(12):1763-80. PubMed ID: 18937118
[TBL] [Abstract][Full Text] [Related]
19. Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease.
Doppler CEJ; Kinnerup MB; Brune C; Farrher E; Betts M; Fedorova TD; Schaldemose JL; Knudsen K; Ismail R; Seger AD; Hansen AK; Stær K; Fink GR; Brooks DJ; Nahimi A; Borghammer P; Sommerauer M
Brain; 2021 Oct; 144(9):2732-2744. PubMed ID: 34196700
[TBL] [Abstract][Full Text] [Related]
20. Morphological alterations of the synapses in the locus coeruleus in Parkinson's disease.
Baloyannis SJ; Costa V; Baloyannis IS
J Neurol Sci; 2006 Oct; 248(1-2):35-41. PubMed ID: 16753180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
